Neuralink Blindsight Device Gains FDA Approval to Restore Vision
Neuralink Blindsight: A Breakthrough in Vision Restoration
Neuralink's experimental implant, Blindsight, has received the prestigious Breakthrough Device Designation from the FDA. This designation is reserved for medical devices with the potential to address life-threatening conditions, accelerating their development and review process.
Vision for the Blind: How Does It Work?
The Blindsight device aims to restore vision for individuals who have lost their eyesight, including those blind from birth. As Elon Musk stated, this groundbreaking technology could enable patients with no optic nerves to perceive visual stimuli, provided their visual cortex remains intact.
- Initial vision quality may resemble low-resolution graphics.
- Future enhancements could surpass natural vision.
- Potential capabilities include seeing in infrared and ultraviolet.
Next Steps for Neuralink
While the details regarding human trials remain under wraps, Neuralink is actively recruiting participants. Their mission to restore sight combines cutting-edge neural technology with a patient-focused approach.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.